In the Media

For Masonic Cancer Center media requests, contact: 

Briana Kerber
Marketing and Communications Manager
kerbe066@umn.edu  


6/09/2023 // "For UMN researchers, finding a better way to educate about cancer starts in the community." Ivan Wu, Masonic Cancer Center member, mentioned. (MPR News)

6/09/2023 // "Cancer survivors who experience functional limitations have doubled in past 20 years." Arjun Gupta, Masonic Cancer Center member, mentioned. (Pharmacy Times)

6/08/2023 // "'Urgent action' needed to address cancer survivors' quality of life: Johns Hopkins." Masonic Cancer Center mentioned. (Becker's Hospital Review)

6/07/2023 // "'The future is here': How virtual reality at U of M helped save woman with brain cancer." Clark Chen, Masonic Cancer Center member, interviewed. (KSTP-TV)

6/07/2023 // "Researchers find functional limitations are increasing in survivors of cancer." Arjun Gupta, Masonic Cancer Center member, mentioned. (Onco'Zine)

6/07/2023 // "Study: Functional limitations among U.S. cancer survivors more than doubled over the past 20 years." Arjun Gupta, Masonic Cancer Center member, mentioned. (News-Medical.net)

6/07/2023 // "Study finds functional limitations increasing in survivors of cancer." Masonic Cancer Center mentioned. (Johns Hopkins Medicine)

6/06/2023 // "University of Minnesota presents 2nd annual Juneteenth celebration and commemorative march: The Art of Freedom." Masonic Cancer Center mentioned. (UMN Twin Cities)

6/05/2023 // "When your lifeline is a cancer-causing mutation." Masonic Cancer Center mentioned. (UMN Twin Cities)

6/03/2023 // "An MRI capable of house calls? University of Minnesota testing concept." Michael Garwood, Masonic Cancer Center member, mentioned. (Star Tribune)

5/24/2023 // "Ozempic in teens is a mess." Aaron Kelly, Masonic Cancer Center member, mentioned. (The Atlantic)

5/22/2023 // "Lars G. Svensson, MD, PhD, assumes presidency of the American Association for Thoracic Surgery." Rosemary Kelly, Masonic Cancer Center member, mentioned. (American Association for Thoracic Surgergy)

5/19/2023 // "Feeling burned out? Here's how a Minnesota doctor sang about it." Stuart Bloom, Masonic Cancer Center member, interviewed. (MPR News)

5/19/2023 // "Weight loss drug reverses obesity for nearly half of teens in study." Aaron Kelly, Masonic Cancer Center member, quoted. (The Washington Post)

5/17/2023 // "Study findings suggest need for ‘urgent push’ to increase diversity in oncology workforce." Anne Blaes, co-leader, SPECS Program, quoted. (Healio)

5/15/2023 // "GT Biopharma reports first quarter 2023 financial results and provides corporate update." Jeffrey Miller, deputy director and co-leader, Immunology Program, mentioned. (GT Biopharma, Inc.)

5/15/2023 // "GT Biopharma reports first quarter 2023 financial results and provides corporate update." Jeffrey Miller, deputy director and co-leader, Immunology Program, mentioned. (Globe Newswire)

5/11/2023 // "AVATAR system helps kids avoid anesthesia in radiotherapy." Stephanie Terezakis, department head, Department of Radiation Oncology, mentioned. (Tech Explorist)

5/10/2023 // “Health Watch: What new mammogram guidance means.” Jessica Kuehn-Hajder, Masonic Cancer Center member, interviewed. (WCCO / CBS Minnesota)

5/9/2023 //  “Study: Black women should begin breast cancer screening earlier than currently recommended.” Dame Idossa, Masonic Cancer Center member, quoted. (Health.com)

5/9/2023 // "HCW Biologics reports first quarter 2023 financial results and recent business highlights." Masonic Cancer Center mentioned. (HCW Biologics)

5/4/2023 // "Long telomeres, the endcaps of DNA, not the fountain of youth once thought—scientists may now know why." Emmanuel Antonarakis, associate director, Translational Research, mentioned. (Johns Hopkins Medicine)

5/1/2023 // "Why we need more Black and Hispanic women in breast cancer clinical trials." Damé Idossa, Masonic Cancer Center member, quoted. (Healthy Women)

4/29/2023 // "XTANDI® (enzalutamide) plus Leuprolide reduced the risk of metastasis by 58% in non-metastatic hormone-sensitive prostate cancer versus placebo plus Leuprolide." Emmanuel Antonarakis, associate director, Translational Research, mentioned. (Astellas Pharma Inc./Pfizer Inc.)

4/27/2023 // "HCW Biologics secures $26.25 million non-dilutive financing with asset-backed development loan." Masonic Cancer Center mentioned. (BioSpace)

4/20/2023 // "New study shows patient/clinician identity differences are a factor in cancer care." Anne Blaes, co-leader, SPECS Program, mentioned. (MedicalXpress.com)

4/19/2023 // “Physician burnout, the musical: One oncologist takes the stage.” Stuart Bloom, Masonic Cancer Center member, quoted. (Becker’s Hospital Review)

4/19/2023 // “A singing oncologist takes on topic of medical burnout in new musical.” Stuart Bloom, Masonic Cancer Center member, quoted. (Kare11)

4/13/2023 // “HCW Biologics Poster Presentation at AACR Annual Meeting 2023.” Masonic Cancer Center mentioned. (Research Pool) 

4/11/2023 // “Novel immunotherapy agent safe, shows promise against high-risk prostate cancers.” Emmanuel Antonarakis, associate director, Translational Research, Masonic Cancer Center, quoted. (PharmaTutor)

4/10/2023 // “Novel immunotherapy agent safe, shows promise against high-risk prostate cancers.” Emmanuel Antonarakis, associate director, Translational Research, Masonic Cancer Center, quoted. (ScienceDaily) 

4/6/2023 // “Novel immunotherapy agent safe, shows promise against high-risk prostate cancers.” Emmanuel Antonarakis, associate director, Translational Research, Masonic Cancer Center, mentioned. (Johns Hopkins Medicine)

4/6/2023 // “Phase 2 study shows safety and efficacy of new drug in men with high-risk prostate cancers.” Emmanuel Antonarakis, associate director, Translational Research, Masonic Cancer Center, mentioned. (News-Medical.net)

4/6/2023 // “Silence in healthy cells makes FOXR2 a potential cancer target.” David Largaespada, associate director for Basic Sciences, Masonic Cancer Center, quoted. (Drug Discovery News)

4/4/2023 // “Impact of piflufolastat F-18 PSMA PET imaging on clinical decision-making in prostate cancer across disease states: A retrospective review.” Emmanuel Antonarakis, associate director, Translational Research, Masonic Cancer Center, quoted. (UroToday)

4/3/2023 // “A novel immunotherapeutic approach to treating aging-associated diseases.” Masonic Cancer Center mentioned. (BioSpace.com)

4/3/2023 // “Neoadjuvant enoblituzumab in localized prostate cancer: a single-arm, phase 2 trial.” Emmanuel Antonarakis, associate director, Translational Research, mentioned. (Nature Medicine)

3/28/2023 // “HCW Biologics reports fourth quarter and full year 2022 financial results and recent business highlights.” Melissa Geller, associate director, Clinical Research, mentioned. (Globe Newswire)

3/28/2023 // “World class hospitals join DNA damage response consortium to bring forward new treatments for adults and children with brain cancer.” William Elmquist, Masonic Cancer Center member, mentioned. (National Brain Tumor Society) 

3/24/2023 // “Prostate cancer: New combination therapy could reduce progression risk.” Nicholas Zorko, Masonic Cancer Center member, quoted. (Medical News Today)

3/23/2023 // “Goldy vs. Cancer seeks to educate youth about cancer.” Elsie Aldrich, events coordinator, Office of Community Outreach and Engagement, quoted. (Minnesota Daily)

3/22/2023 // “Cases of colorectal cancer on the rise among younger Americans.” Emil Lou, Masonic Cancer Center member, quoted. (Kare11)

3/21/2023 // “Minnesota students, educators call on lawmakers to act on flavored tobacco.” Masonic Cancer Center mentioned. (ABC 27 WHTM) 

3/13/2023 // “Improved medical treatment and health equity may be a test away.” Aleta Stevens, regulatory specialist, cancer clinical trials, authored op-ed. (MinnPost) 

3/11/2023 // “Researchers say sleep problems lead to health disparities for Black and brown Minnesotans.” Masonic Cancer Center mentioned. (StarTribune)

3/9/2023 // “Poor sleep hurts Black health, Minnesota researchers say.” Masonic Cancer Center mentioned. (MPR News)

3/7/2023 // “Black and brown Minnesotans get worse sleep than white people. Researchers at the University of Minnesota say it’s hurting their health.” Masonic Cancer Center mentioned. (Sahan Journal) 

3/1/2023 // “New cell-based assay shown to rapidly profile drug resistance to three widely used SARS-CoV-2 main protease inhibiting drugs.” Daniel Harki, co-leader, Cellular Mechanisms Program, mentioned. (News-Medical.net)

2/22/2023 // “Patient navigators help people of color get better cancer care, research shows.” Rahel Ghebre, associate director, diversity, equity, and inclusion, quoted. (MPR News)

2/13/2023 // “Cancer treatment is a minefield of bills, meds, and jargon. Patient navigators can help people of color find a path to better care.” Rahel Ghebre, associate director, diversity, equity, and inclusion, quoted. (Sahan Journal)

2/1/2023 // “Grand Rapids meeting highlights contrasting views on Sanford-Fairview megamerger.” Bevan Yueh, chief executive officer, U of M Physicians, quoted. (StarTribune) 

1/30/2023 // “Kulasingam honored with Sara Evans Faculty Woman Scholar/Leader Award.” Shalini Kulasingam, Masonic Cancer Center member, quoted. (UMN School of Public Health)

1/30/2023 // “The case of the incredibly long-lived mouse cells.” David Masopust, Masonic Cancer Center member, quoted. (Wired)

1/27/2023 // “New U of M research suggests race may factor into brain tumor care.” Andrew Venteicher, Masonic Cancer Center member, quoted. (MinnPost)

1/26/2023 // “Letter: Sanford-Fairview merger will make healthcare more sustainable for rural Minnesotans.” Masonic Cancer Center mentioned. (The Worthington Globe)

1/26/2023 // “Why are some lung cancers resistant to treatment? A Hormel Institute professor wants to answer that question.” Masonic Cancer Center mentioned. (Rochester Post Bulletin)

1/25/2023 // “Proposed Sanford-Fairview merger draws mixed reactions in Worthington.” Bevan Yueh, chief executive officer, U of M Physicians, quoted. (The Worthington Globe) 

1/15/2023 // “Minnesota bladder cancer resources.” Masonic Cancer Center mentioned. (Bladder Cancer Advocacy Network) 

1/15/2023 // “Eagles Cancer Telethon tops $1 million as Chapman exits.” Masonic Cancer Center mentioned. (Rochester Post Bulletin) 

1/10/2023 // “69th annual Eagles Cancer Telethon starts Saturday.” Masonic Cancer Center mentioned. (KTTC) 

1/9/2023 // “The Hormel Institute Scientists publish research that could lead to better understanding of how Alzheimer’s disease develops.” Masonic Cancer Center mentioned. (The Hormel Institute) 

1/6/2023 // “Top Story: Cautionary tale of a devastating health diagnosis: brain tumors.” Lindsey Sloan, Masonic Cancer Center member, quoted. (U of M Medical School)

1/6/2023 // “'I donated in the '70s' | Longtime blood donors share why they keep coming back.” Claudia Cohn, Masonic Cancer Center member, quoted. (Kare11)

1/5/2023 // “Escape the Vape Video Challenge.” Masonic Cancer Center mentioned. (Minnesota Department of Health)

1/5/2023 // “Global cell expansion market is likely to grow at a CAGR value of around 14.8% by 2028.” Branden Moriarity, co-director, Genome Engineering Shared Resource, mentioned. (Newswires)

1/4/2023 // “Cautionary tale of a devastating health diagnosis: brain tumors.” Lindsey Sloan, Masonic Cancer Center member, mentioned. (CBS Minnesota) 

1/3/2023 // “Is protein expression the key to personalized ovarian cancer treatments?” Stefani Thomas, Masonic Cancer Center member, quoted. (Victory Over Cancer Research Foundation) 

12/29/2022 // “Could getting rid of old cells help people live disease-free for longer?” Laura Niedernhofer, Masonic Cancer Center member, quoted. (Smithsonian Magazine)

12/28/2022 // “An effective obesity drug has now been approved for teens.” Aaron Kelly, Masonic Cancer Center member, quoted. (Gizmodo)

12/27/2022 // “Expert Video - What is a clinical trial for lung cancer?” Manish Patel, Masonic Cancer Center member, quoted. (A Breath of Hope Lung Foundation)

12/22/2022 // “Reshaping cancer clinical trials to reflect current needs and progress.” Douglas Yee, director, quoted. (American Association for Cancer Research)

12/21/2022 // “Looking for medicine for a sick kid? You may be out of luck.” Beth Thielen, Masonic Cancer Center member, quoted. (MPR News)

12/20/2022 // “University regents consider new rural physician training program with CentraCare, would include Willmar area.” Jakub Tolar, dean, U of M Medical School, mentioned. (West Central Tribune)

12/16/2022 // “U of M Institute for Therapeutics Discovery and Development (ITDD) selected for participation in a national Chemical Biology Consortium.” Douglas Yee, director, quoted. (U of M College of Pharmacy)

12/14/2022 // “Tidings of cup-fort and dangers.” Traci Toomey, Masonic Cancer Center member, quoted. (Minnesota Daily)

12/9/2022 // “Black patients with brain tumors less likely to get surgery than whites.” Andrew Venteicher, Masonic Cancer Center member, quoted. (Casper Star Tribune)

12/5/2022 // “Biomarker analysis to identify molecular signatures predictive of response in the COMBAT study.” Emmanuel Antonarakis, associate director, Translational Research, interviewed. (UroToday)